The Therapeutic Effect of Gamma Interferon in Advanced Renal Cell Carcinoma.
- Author:
Jai Young YOON
1
;
Yong Hyun CHO
;
Moon Soo YOON
;
Su Kil LIM
Author Information
1. Catholic University Medical College, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
advanced renal cell carcinoma;
gamma interferon
- MeSH:
Carcinoma, Renal Cell*;
Fatigue;
Fever;
Humans;
Interferons*;
Leukopenia;
Myalgia;
Urology
- From:Korean Journal of Urology
1990;31(4):508-512
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We evaluated the antitumor activity and toxicity of recombinant human interferon gamma (LBD -001) as a new modality for advanced renal cell carcinoma from March, 1988 to August, 1989 at the Department of Urology, St. Mary's Hospital, Catholic University Medical College. Eleven patients with advanced renal cell carcinoma were given recombinant gamma interferon at dose of 5.0-7.6 x 106U/day, subcutaneously three days per week. Among eleven patients, only one achieved partial response. Major adverse effects included fever, fatigue, myalgia and leukopenia, but no life threatening side effects were found. Although recombinant human interferon gamma have an antitumor activity against advanced renal cell carcinoma, further study is necessary to define the optimal treatment regimen.
